**Core Concept**
Massive transfusion can lead to **dilutional coagulopathy**, a condition where the transfused blood lacks sufficient clotting factors, causing an imbalance in the coagulation cascade. This situation can arise when a large volume of blood is transfused in a short period, typically more than one blood volume in 24 hours. The underlying principle involves the **coagulation pathway** and its components.

**Why the Correct Answer is Right**
The correct answer is related to the dilution of clotting factors, particularly **fibrinogen**, **prothrombin**, and **platelets**, which are essential for blood coagulation. When these factors are diluted below a certain threshold, the blood's ability to form clots is impaired, leading to **hemorrhage**. This mechanism is crucial in understanding the complications associated with massive transfusion.

**Why Each Wrong Option is Incorrect**
**Option A:** Incorrect because it is not directly related to the coagulopathy caused by massive transfusion.
**Option B:** Incorrect as it does not accurately describe the primary cause of hemorrhage in this context.
**Option C:** Incorrect because, although it might be a consideration in transfusion medicine, it is not the primary reason for hemorrhage due to massive transfusion.

**Clinical Pearl / High-Yield Fact**
A key point to remember is that **dilutional coagulopathy** can be managed by transfusing **fresh frozen plasma (FFP)** and **platelets** to replenish the depleted clotting factors. Monitoring of coagulation parameters is essential in patients receiving massive transfusions.

**Correct Answer:** D. Dilutional coagulopathy.